Advertisement
1/26 - Just How Dangerous Is Coronavirus to the Middle-Aged?

COVID-19 Also Hazardous for Middle-Aged Adults

0

Age-specific infection fatality rate very low for children and younger adults, but increases progressively among adults

HealthDay Reports: Scientists Say New Coronavirus Can Linger in Indoor Air

Brazilian Coronavirus Variant Found in Minnesota

0

No immediate indication seen that the variant is spreading in the state

Cómo dormir mejor en 2021

Women More Likely to Suffer Nighttime Sudden Cardiac Death

0

Other independent risk factors include central nervous system-affecting drugs and COPD or asthma

B 11/5 Smoking Bans May Not Guard Against Secondhand Smoke: Study

Smoking History Tied to Worse COVID-19 Outcomes

0

Risk for hospitalization, death higher for both current and former smokers

Sixty-Day Outcomes Examined for Hospitalized COVID-19 Patients

COVID-19 Outcomes No Worse for Patients on Immunosuppressive Meds

0

Findings for ventilator use, length of stay, in-hospital mortality similar for those with, without chronic use of immunosuppressant agents

No Evidence Found to Support Discontinuing ACEIs, ARBs in COVID-19

0

Mean number of days alive and out of hospital not significantly different for those discontinuing, continuing meds

HealthDay Reports: Coronavirus May Be Seasonal After All

Moderna COVID-19 Vaccine Effective Against British, South African Variants

0

Company says it is working on a new form of the vaccine to use as a booster shot against the South African variant

HD Live!: An Interview With Dr. Anthony Fauci

Fauci Awarded Medal by Academy of Sciences

0

Medal is the academy's most prestigious award, presented annually to honor extraordinary use of science for the public good

ASH: Daratumumab + Pomalidomide

2.5 Anaphylaxis Cases Reported Per Million COVID-19 Moderna Vaccine Shots

0

Nine of the 10 cases occurred in individuals with documented history of allergies, allergic reactions

ASH

Groups Jointly Issue Guidelines for Von Willebrand Disease

0

ASH, ISTH, NHF, and WFH developed clinical guidelines for the diagnosis, management of von Willebrand disease